(+)-catechin decreases expression ISO RGD:2202 6480464 Catechin results in decreased expression of BDNF protein CTD PMID:22886603 (+)-epicatechin-3-O-gallate multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF protein]] more ... CTD PMID:29061316 (+)-pilocarpine increases expression ISO RGD:10235 6480464 Pilocarpine results in increased expression of BDNF protein modified form CTD PMID:19397936 (+)-pilocarpine increases expression ISO RGD:2202 6480464 Pilocarpine results in increased expression of BDNF exon more ... CTD PMID:11259499 more ... (+)-pilocarpine decreases expression ISO RGD:2202 6480464 Pilocarpine results in decreased expression of BDNF protein CTD PMID:11259499 (+)-pilocarpine multiple interactions ISO RGD:2202 6480464 1 alpha more ... CTD PMID:11259499 more ... (-)-epigallocatechin 3-gallate decreases expression ISO RGD:2202 6480464 epigallocatechin gallate results in decreased expression of BDNF protein CTD PMID:22886603 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF protein]] more ... CTD PMID:29061316 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:10235 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein] CTD PMID:24394491 (20S)-ginsenoside Rg3 multiple interactions EXP 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein], [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [[Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]] CTD PMID:24394491 (R)-Salsolinol decreases expression ISO RGD:2202 6480464 salsolinol results in decreased expression of BDNF protein CTD PMID:23261589 (S)-3,5-dihydroxyphenylglycine decreases activity ISO RGD:10235 6480464 BDNF protein results in decreased activity of 3, 5-dihydroxyphenylglycine CTD PMID:20554863 (S)-AMPA increases expression ISO RGD:2202 6480464 alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid results in increased expression of BDNF protein CTD PMID:11279263 (S)-amphetamine increases expression ISO RGD:10235 6480464 Dextroamphetamine results in increased expression of BDNF mRNA CTD PMID:18681898 (S)-amphetamine decreases expression ISO RGD:2202 6480464 Dextroamphetamine results in decreased expression of BDNF protein CTD PMID:16460767 , PMID:17434716 (S)-amphetamine multiple interactions ISO RGD:2202 6480464 Lithium inhibits the reaction [Dextroamphetamine results in decreased expression of BDNF protein], Valproic Acid inhibits the reaction [Dextroamphetamine results in decreased expression of BDNF protein] CTD PMID:16460767 (S)-amphetamine increases expression ISO RGD:2202 6480464 Dextroamphetamine results in increased expression of BDNF mRNA, Dextroamphetamine results in increased expression of BDNF protein CTD PMID:12213320 , PMID:27373168 (S)-amphetamine affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Dextroamphetamine CTD PMID:16823800 (S)-amphetamine affects expression ISO RGD:2202 6480464 Dextroamphetamine affects the expression of BDNF mRNA CTD PMID:19222557 (S)-colchicine decreases transport ISO RGD:2202 6480464 Colchicine results in decreased transport of BDNF protein CTD PMID:21310905 (S)-nicotine affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Nicotine CTD PMID:17186223 (S)-nicotine affects expression ISO RGD:2202 6480464 Nicotine affects the expression of BDNF mRNA CTD PMID:20426880 (S)-nicotine increases expression ISO RGD:2202 6480464 Nicotine results in increased expression of BDNF mRNA CTD PMID:9503263 , PMID:9832142 (S)-nicotine increases secretion EXP 6480464 Nicotine results in increased secretion of BDNF protein CTD PMID:16790237 (S)-nicotine multiple interactions EXP 6480464 methyllycaconitine inhibits the reaction [Nicotine results in increased secretion of BDNF protein] CTD PMID:16790237 1,1-dichloroethene decreases expression ISO RGD:10235 6480464 vinylidene chloride results in decreased expression of BDNF mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:2202 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in decreased expression of BDNF mRNA CTD PMID:27840820 1-bromopropane decreases expression ISO RGD:10235 6480464 1-bromopropane results in decreased expression of BDNF mRNA CTD PMID:19189864 1-bromopropane decreases expression ISO RGD:2202 6480464 1-bromopropane results in decreased expression of BDNF mRNA CTD PMID:23266320 1-bromopropane multiple interactions ISO RGD:10235 6480464 1-bromopropane inhibits the reaction [Colforsin results in increased expression of BDNF protein] CTD PMID:19189864 1-bromopropane decreases expression EXP 6480464 1-bromopropane results in decreased expression of BDNF mRNA CTD PMID:19189864 1-bromopropane multiple interactions EXP 6480464 1-bromopropane inhibits the reaction [Bucladesine results in increased expression of BDNF mRNA] more ... CTD PMID:19189864 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:2202 6480464 Dinitrochlorobenzene inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid] CTD PMID:19428112 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:10235 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:10235 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:10235 6480464 geraniol inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 more ... 13,14-dihydro-Delta(12)-prostaglandin J2 increases expression ISO RGD:2202 6480464 9-deoxy-9 more ... CTD PMID:22982731 13,14-dihydro-Delta(12)-prostaglandin J2 multiple interactions ISO RGD:2202 6480464 Dactinomycin inhibits the reaction [9-deoxy-9 more ... CTD PMID:22982731 17alpha-ethynylestradiol decreases methylation ISO RGD:2202 6480464 Ethinyl Estradiol results in decreased methylation of BDNF promoter CTD PMID:30001178 17beta-estradiol multiple interactions ISO RGD:2202 6480464 Estradiol inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BDNF mRNA], Progesterone inhibits the reaction [Estradiol results in increased expression of BDNF protein] CTD PMID:15570173 , PMID:29425760 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of BDNF mRNA CTD PMID:23373633 17beta-estradiol increases expression ISO RGD:2202 6480464 Estradiol results in increased expression of BDNF mRNA, Estradiol results in increased expression of BDNF protein CTD PMID:15570173 , PMID:29425760 17beta-estradiol 3-benzoate decreases expression ISO RGD:2202 6480464 estradiol 3-benzoate results in decreased expression of BDNF mRNA CTD PMID:21277884 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:2202 6480464 2 more ... CTD PMID:21436126 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:2202 6480464 2 more ... CTD PMID:21436126 2,2',4,4'-Tetrabromodiphenyl ether decreases methylation ISO RGD:2202 6480464 2 more ... CTD PMID:25533936 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10235 6480464 Tetrachlorodibenzodioxin results in increased expression of BDNF mRNA CTD PMID:15328365 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10235 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BDNF promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2202 6480464 Tetrachlorodibenzodioxin affects the expression of BDNF mRNA CTD PMID:12606293 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:2202 6480464 2 more ... CTD PMID:22024335 , PMID:23578391 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine multiple interactions ISO RGD:10235 6480464 [Poly I-C results in increased susceptibility to 4-iodo-2 more ... CTD PMID:24889602 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine increases expression ISO RGD:10235 6480464 4-iodo-2, 5-dimethoxyphenylisopropylamine results in increased expression of BDNF mRNA CTD PMID:24889602 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:10235 6480464 Glucosamine results in decreased expression of BDNF mRNA CTD PMID:17178593 2-methyl-6-(phenylethynyl)pyridine multiple interactions ISO RGD:2202 6480464 BDNF protein inhibits the reaction [6-methyl-2-(phenylethynyl)pyridine results in decreased expression of GRM1 protein] CTD PMID:21232601 2-methyl-6-(phenylethynyl)pyridine decreases expression ISO RGD:2202 6480464 6-methyl-2-(phenylethynyl)pyridine results in decreased expression of BDNF protein CTD PMID:21232601 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10235 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of BDNF mRNA CTD PMID:19285098 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:2202 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BDNF protein CTD PMID:27373168 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA more ... CTD PMID:29698629 3-nitropropanoic acid decreases response to substance ISO RGD:2202 6480464 BDNF protein results in decreased susceptibility to 3-nitropropionic acid CTD PMID:19428112 3-nitropropanoic acid decreases expression ISO RGD:2202 6480464 3-nitropropionic acid results in decreased expression of BDNF protein CTD PMID:29753867 3-nitropropanoic acid multiple interactions ISO RGD:2202 6480464 BCL2 protein promotes the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid] more ... CTD PMID:19428112 , PMID:29753867 3H-1,2-dithiole-3-thione increases expression ISO RGD:2202 6480464 1, 2-dithiol-3-thione results in increased expression of BDNF mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:10235 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of BDNF mRNA CTD PMID:30951980 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO RGD:10235 6480464 4 more ... CTD PMID:26301327 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol multiple interactions ISO RGD:2202 6480464 ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein] CTD PMID:24718106 4-hydroxynon-2-enal decreases expression ISO RGD:2202 6480464 4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA CTD PMID:16337876 4-hydroxynon-2-enal multiple interactions ISO RGD:2202 6480464 CREBBP protein inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA] CTD PMID:16337876 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of BDNF mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine increases expression ISO RGD:2202 6480464 Decitabine results in increased expression of BDNF mRNA CTD PMID:19476549 5-azacytidine increases expression ISO RGD:10235 6480464 Azacitidine results in increased expression of BDNF mRNA CTD PMID:18184782 5-azacytidine decreases methylation ISO RGD:10235 6480464 Azacitidine results in decreased methylation of BDNF promoter CTD PMID:18184782 5-azacytidine multiple interactions ISO RGD:10235 6480464 Tetrodotoxin inhibits the reaction [Azacitidine results in decreased methylation of BDNF promoter], Tetrodotoxin inhibits the reaction [Azacitidine results in increased expression of BDNF mRNA] CTD PMID:18184782 5-fluorouracil decreases expression ISO RGD:2202 6480464 Fluorouracil results in decreased expression of BDNF protein CTD PMID:18702703 6-anilino-5,8-quinolinedione decreases response to substance EXP 6480464 BDNF protein results in decreased susceptibility to 6-anilino-5, 8-quinolinedione CTD PMID:22261313 6-Cyano-7-nitroquinoxaline-2,3-dione multiple interactions ISO RGD:2202 6480464 6-Cyano-7-nitroquinoxaline-2, 3-dione inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA alternative form] CTD PMID:15183516 6-propyl-2-thiouracil increases expression ISO RGD:2202 6480464 Propylthiouracil results in increased expression of BDNF mRNA CTD PMID:25825206 [6]-Shogaol multiple interactions ISO RGD:10235 6480464 [shogaol co-treated with Hydrogen Peroxide] results in increased expression of BDNF mRNA more ... CTD PMID:22381256 [6]-Shogaol increases expression ISO RGD:10235 6480464 [shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein, [shogaol results in increased expression of BDNF protein] which results in increased expression of SLC5A7 protein CTD PMID:22381256 acrolein multiple interactions ISO RGD:2202 6480464 CREBBP protein inhibits the reaction [Acrolein results in decreased expression of BDNF mRNA] CTD PMID:16337876 acrolein decreases expression ISO RGD:2202 6480464 Acrolein results in decreased expression of BDNF mRNA, Acrolein results in decreased expression of BDNF protein CTD PMID:16337876 , PMID:29355571 actinomycin D multiple interactions ISO RGD:2202 6480464 Dactinomycin inhibits the reaction [9-deoxy-9 more ... CTD PMID:22982731 actinomycin D decreases expression ISO RGD:2202 6480464 Dactinomycin results in decreased expression of BDNF mRNA CTD PMID:22982731 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BDNF mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of BDNF gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:2202 6480464 Aflatoxin B1 results in decreased expression of BDNF mRNA CTD PMID:26260870 agathisflavone multiple interactions ISO RGD:2202 6480464 agathisflavone inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BDNF mRNA] CTD PMID:29425760 agathisflavone increases expression ISO RGD:2202 6480464 agathisflavone results in increased expression of BDNF mRNA CTD PMID:29425760 agomelatine increases expression ISO RGD:2202 6480464 S 20098 results in increased expression of BDNF protein CTD PMID:22160164 agomelatine increases expression ISO RGD:10235 6480464 S 20098 results in increased expression of BDNF mRNA CTD PMID:19775499 alcohol decreases expression ISO RGD:10235 6480464 Alcohols results in decreased expression of BDNF mRNA CTD PMID:29391279 aldehydo-D-glucosamine decreases expression ISO RGD:10235 6480464 Glucosamine results in decreased expression of BDNF mRNA CTD PMID:17178593 all-trans-retinoic acid multiple interactions EXP 6480464 [BDNF protein co-treated with Tretinoin] results in increased expression of APP protein, BDNF protein inhibits the reaction [Tretinoin results in increased N-linked glycosylation of APLP1 protein] CTD PMID:16150056 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BDNF mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:10235 6480464 Tretinoin results in decreased expression of BDNF protein CTD PMID:17026715 alpha-D-galactose decreases expression ISO RGD:10235 6480464 Galactose results in decreased expression of BDNF mRNA, Galactose results in decreased expression of BDNF protein CTD PMID:28974442 alpha-D-galactose multiple interactions ISO RGD:10235 6480464 lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA], lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein] CTD PMID:28974442 amantadine multiple interactions ISO RGD:2202 6480464 [Fluoxetine co-treated with Amantadine] results in increased expression of BDNF mRNA CTD PMID:19211973 ammonium chloride affects expression ISO RGD:2202 6480464 Ammonium Chloride affects the expression of BDNF mRNA CTD PMID:16483693 amphetamine affects response to substance ISO RGD:10235 6480464 BDNF gene mutant form affects the susceptibility to Amphetamine CTD PMID:11421589 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [BDNF protein results in increased expression of SOD2 protein] CTD PMID:22261313 apigenin multiple interactions ISO RGD:2202 6480464 Apigenin inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA] CTD PMID:28389404 arachidonic acid decreases expression EXP 6480464 Arachidonic Acid results in decreased expression of BDNF mRNA CTD PMID:16704987 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein CTD PMID:24394491 Aroclor 1254 decreases expression ISO RGD:10235 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein CTD PMID:24394491 Aroclor 1254 multiple interactions ISO RGD:10235 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein] CTD PMID:24394491 Aroclor 1254 multiple interactions EXP 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein] more ... CTD PMID:24394491 arsane decreases expression ISO RGD:10235 6480464 Arsenic results in decreased expression of BDNF mRNA CTD PMID:19654921 arsane multiple interactions ISO RGD:2202 6480464 BDNF protein inhibits the reaction [Arsenic results in decreased phosphorylation of NTRK2 protein] more ... CTD PMID:28903487 arsane decreases expression ISO RGD:2202 6480464 Arsenic results in decreased expression of BDNF mRNA, Arsenic results in decreased expression of BDNF protein CTD PMID:28903487 arsenic atom decreases expression ISO RGD:10235 6480464 Arsenic results in decreased expression of BDNF mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:2202 6480464 Arsenic results in decreased expression of BDNF mRNA, Arsenic results in decreased expression of BDNF protein CTD PMID:28903487 arsenic atom multiple interactions ISO RGD:2202 6480464 BDNF protein inhibits the reaction [Arsenic results in decreased phosphorylation of NTRK2 protein] more ... CTD PMID:28903487 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of BDNF mRNA CTD PMID:23744399 , PMID:23974009 arsenite(3-) increases methylation EXP 6480464 arsenite results in increased methylation of BDNF promoter CTD PMID:23974009 arsenite(3-) multiple interactions EXP 6480464 Taurine inhibits the reaction [arsenite results in decreased expression of BDNF mRNA] CTD PMID:23744399 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BDNF protein CTD PMID:16711005 arsenous acid multiple interactions ISO RGD:10235 6480464 Arsenic Trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein] CTD PMID:26114099 arsenous acid decreases expression ISO RGD:2202 6480464 Arsenic Trioxide results in decreased expression of BDNF mRNA CTD PMID:29223816 Asiaticoside increases expression ISO RGD:2202 6480464 asiaticoside results in increased expression of BDNF mRNA CTD PMID:28238857 Asiaticoside multiple interactions ISO RGD:2202 6480464 asiaticoside inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA] CTD PMID:28238857 atrazine increases expression EXP 6480464 Atrazine results in increased expression of BDNF mRNA CTD PMID:18585445 atrazine decreases expression ISO RGD:2202 6480464 Atrazine results in decreased expression of BDNF mRNA, Atrazine results in decreased expression of BDNF protein CTD PMID:30065202 Bay-K-8644 multiple interactions ISO RGD:2202 6480464 3-Pyridinecarboxylic acid, 1 more ... CTD PMID:11279263 , PMID:22079160 Bay-K-8644 increases expression ISO RGD:2202 6480464 3-Pyridinecarboxylic acid, 1 more ... CTD PMID:11279263 benzo[a]pyrene increases expression ISO RGD:2202 6480464 Benzo(a)pyrene results in increased expression of BDNF mRNA CTD PMID:21839799 benzo[a]pyrene increases expression ISO RGD:10235 6480464 Benzo(a)pyrene results in increased expression of BDNF mRNA CTD PMID:22610609 benzo[a]pyrene decreases expression ISO RGD:2202 6480464 Benzo(a)pyrene results in decreased expression of BDNF protein CTD PMID:21467743 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 beta-D-glucosamine decreases expression ISO RGD:10235 6480464 Glucosamine results in decreased expression of BDNF mRNA CTD PMID:17178593 bis(2-chloroethyl) sulfide increases expression ISO RGD:10235 6480464 Mustard Gas results in increased expression of BDNF mRNA CTD PMID:15674844 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 bisphenol A multiple interactions ISO RGD:10235 6480464 bisphenol A inhibits the reaction [Potassium results in increased expression of BDNF mRNA] CTD PMID:15527870 bisphenol A increases methylation ISO RGD:2202 6480464 bisphenol A results in increased methylation of BDNF promoter CTD PMID:30001178 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BDNF protein CTD PMID:31339859 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BDNF mRNA CTD PMID:29275510 , PMID:29718440 bisphenol A decreases methylation ISO RGD:10235 6480464 bisphenol A results in decreased methylation of BDNF promoter CTD PMID:27312807 bisphenol A decreases expression ISO RGD:2202 6480464 bisphenol A results in decreased expression of BDNF mRNA CTD PMID:25181051 more ... bisphenol A affects expression ISO RGD:10235 6480464 bisphenol A affects the expression of BDNF mRNA CTD PMID:25385582 bisphenol A increases methylation ISO RGD:10235 6480464 bisphenol A results in increased methylation of BDNF promoter CTD PMID:25385582 bisphenol A multiple interactions ISO RGD:2202 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of BDNF mRNA CTD PMID:25607892 bisphenol A decreases phosphorylation ISO RGD:2202 6480464 bisphenol A results in decreased phosphorylation of BDNF protein CTD PMID:26827910 bisphenol A decreases expression ISO RGD:10235 6480464 bisphenol A results in decreased expression of BDNF mRNA, bisphenol A results in decreased expression of BDNF protein CTD PMID:22484357 more ... bisphenol F decreases expression ISO RGD:2202 6480464 4, 4'-bisphenol F results in decreased expression of BDNF mRNA CTD PMID:26186136 bisphenol F increases expression ISO RGD:10235 6480464 bisphenol F results in increased expression of BDNF mRNA CTD PMID:30951980 bromocriptine decreases secretion ISO RGD:10235 6480464 Bromocriptine results in decreased secretion of BDNF protein CTD PMID:12770616 bucladesine multiple interactions EXP 6480464 1-bromopropane inhibits the reaction [Bucladesine results in increased expression of BDNF mRNA] more ... CTD PMID:19189864 , PMID:29698629 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of BDNF mRNA CTD PMID:19189864 buprenorphine decreases expression ISO RGD:2202 6480464 Buprenorphine results in decreased expression of BDNF protein CTD PMID:24321744 C60 fullerene decreases expression ISO RGD:2202 6480464 fullerene C60 results in decreased expression of BDNF mRNA, fullerene C60 results in decreased expression of BDNF protein CTD PMID:29191454 cadmium atom multiple interactions ISO RGD:10235 6480464 [Cadmium results in decreased transport of Calcium] inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] CTD PMID:16553631 cadmium dichloride multiple interactions ISO RGD:2202 6480464 [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of BDNF protein, zinc chloride affects the reaction [Cadmium Chloride affects the expression of BDNF mRNA] CTD PMID:23680456 , PMID:29548726 cadmium dichloride affects expression ISO RGD:2202 6480464 Cadmium Chloride affects the expression of BDNF mRNA CTD PMID:29548726 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BDNF protein CTD PMID:26138014 cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of BDNF protein] CTD PMID:26138014 cadmium dichloride increases methylation ISO RGD:2202 6480464 Cadmium Chloride results in increased methylation of BDNF promoter CTD PMID:22457795 caffeine multiple interactions ISO RGD:2202 6480464 Caffeine inhibits the reaction [aluminum chloride results in decreased expression of BDNF mRNA] CTD PMID:26339337 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of BDNF mRNA CTD PMID:16002434 calcium atom multiple interactions ISO RGD:10235 6480464 [Cadmium results in decreased transport of Calcium] inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein], Calcium affects the reaction [Oxygen deficiency results in increased secretion of BDNF protein] CTD PMID:16553631 calcium atom multiple interactions EXP 6480464 3 more ... CTD PMID:26095976 calcium atom increases transport EXP 6480464 BDNF protein results in increased transport of Calcium CTD PMID:26095976 calcium(0) multiple interactions ISO RGD:10235 6480464 [Cadmium results in decreased transport of Calcium] inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein], Calcium affects the reaction [Oxygen deficiency results in increased secretion of BDNF protein] CTD PMID:16553631 calcium(0) increases transport EXP 6480464 BDNF protein results in increased transport of Calcium CTD PMID:26095976 calcium(0) multiple interactions EXP 6480464 3 more ... CTD PMID:26095976 cannabidiol increases expression ISO RGD:2202 6480464 Cannabidiol results in increased expression of BDNF protein CTD PMID:19939866 capsaicin multiple interactions ISO RGD:2202 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of BDNF protein] more ... CTD PMID:22150557 capsaicin affects expression ISO RGD:2202 6480464 Capsaicin affects the expression of BDNF protein CTD PMID:22150557 carbamazepine increases expression ISO RGD:2202 6480464 Carbamazepine results in increased expression of BDNF mRNA, Carbamazepine results in increased expression of BDNF protein CTD PMID:18719996 carbon dioxide multiple interactions ISO RGD:2202 6480464 [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein more ... CTD PMID:24718106 carbon monoxide decreases expression ISO RGD:2202 6480464 Carbon Monoxide results in decreased expression of BDNF mRNA CTD PMID:27113706 carbon monoxide multiple interactions ISO RGD:2202 6480464 Carbon Monoxide results in decreased expression of and results in decreased secretion of BDNF protein CTD PMID:27113706 carbon nanotube decreases expression ISO RGD:10235 6480464 Nanotubes, Carbon analog results in decreased expression of BDNF mRNA, Nanotubes, Carbon results in decreased expression of BDNF mRNA CTD PMID:25554681 chloroprene increases expression ISO RGD:10235 6480464 Chloroprene results in increased expression of BDNF mRNA CTD PMID:23125180 chlorpromazine affects response to substance EXP 6480464 BDNF affects the susceptibility to Chlorpromazine CTD PMID:18408624 chlorpyrifos affects expression ISO RGD:2202 6480464 Chlorpyrifos affects the expression of BDNF mRNA CTD PMID:18502319 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with BDNF protein] results in decreased activity of ACHE protein, Chlorpyrifos inhibits the reaction [BDNF protein results in increased activity of BCHE protein] CTD PMID:30200437 chlorpyrifos increases expression ISO RGD:2202 6480464 Chlorpyrifos results in increased expression of BDNF mRNA, Chlorpyrifos results in increased expression of BDNF protein CTD PMID:17893397 , PMID:26775027 cholesterol multiple interactions ISO RGD:2202 6480464 [Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein, Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein] CTD PMID:30695686 choline multiple interactions ISO RGD:10235 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BDNF gene CTD PMID:20938992 chondroitin sulfate affects binding EXP 6480464 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to BDNF protein CTD PMID:15385557 chrysin multiple interactions ISO RGD:10235 6480464 chrysin inhibits the reaction [Oxidopamine results in decreased expression of BDNF protein] CTD PMID:29054324 chrysin increases expression ISO RGD:10235 6480464 chrysin results in increased expression of BDNF protein CTD PMID:29054324 cisplatin decreases expression ISO RGD:2202 6480464 Cisplatin results in decreased expression of BDNF mRNA CTD PMID:22023808 cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of BDNF mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of BDNF mRNA] CTD PMID:27392435 Citreoviridin affects expression ISO RGD:10235 6480464 citreoviridin affects the expression of BDNF mRNA CTD PMID:30071239 clofibrate increases expression ISO RGD:10235 6480464 Clofibrate results in increased expression of BDNF mRNA CTD PMID:17585979 clopidogrel decreases secretion EXP 6480464 clopidogrel results in decreased secretion of BDNF protein CTD PMID:21803431 clozapine decreases expression ISO RGD:2202 6480464 Clozapine results in decreased expression of BDNF mRNA CTD PMID:11488957 clozapine increases expression ISO RGD:2202 6480464 Clozapine results in increased expression of BDNF mRNA, Clozapine results in increased expression of BDNF protein CTD PMID:12478621 , PMID:17442489 cocaine decreases response to substance EXP 6480464 BDNF mRNA results in decreased susceptibility to Cocaine, BDNF protein results in decreased susceptibility to Cocaine CTD PMID:17194538 cocaine increases expression ISO RGD:10235 6480464 Cocaine results in increased expression of BDNF mRNA CTD PMID:12099907 more ... cocaine decreases activity ISO RGD:10235 6480464 Cocaine results in decreased activity of BDNF protein CTD PMID:24358339 cocaine increases expression ISO RGD:2202 6480464 Cocaine results in increased expression of BDNF protein CTD PMID:18311559 , PMID:20711185 cocaine affects expression ISO RGD:2202 6480464 Cocaine affects the expression of BDNF exon more ... CTD PMID:14973246 more ... cocaine multiple interactions ISO RGD:2202 6480464 BDNF protein inhibits the reaction [Cocaine results in increased abundance of Amino Acids, Peptides, and Proteins] more ... CTD PMID:17618281 more ... cocaine decreases response to substance ISO RGD:2202 6480464 BDNF mRNA results in decreased susceptibility to Cocaine more ... CTD PMID:17194538 , PMID:20810894 cocaine multiple interactions ISO RGD:10235 6480464 (+)-JQ1 compound inhibits the reaction [Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]] more ... CTD PMID:18355967 more ... cocaine decreases expression ISO RGD:10235 6480464 Cocaine results in decreased expression of BDNF mRNA, Cocaine results in decreased expression of BDNF protein CTD PMID:18355967 more ... cocaine increases response to substance ISO RGD:10235 6480464 BDNF results in increased susceptibility to Cocaine CTD PMID:17618281 Colforsin dapropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of BDNF mRNA, Colforsin results in increased expression of BDNF protein CTD PMID:19189864 Colforsin dapropate hydrochloride multiple interactions EXP 6480464 1-bromopropane inhibits the reaction [Colforsin results in increased expression of BDNF mRNA], 1-bromopropane inhibits the reaction [Colforsin results in increased expression of BDNF protein] CTD PMID:19189864 Colforsin dapropate hydrochloride increases expression ISO RGD:10235 6480464 Colforsin results in increased expression of BDNF protein CTD PMID:19189864 Colforsin dapropate hydrochloride multiple interactions ISO RGD:10235 6480464 1-bromopropane inhibits the reaction [Colforsin results in increased expression of BDNF protein] CTD PMID:19189864 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of BDNF mRNA CTD PMID:24690739 copper atom affects binding EXP 6480464 Copper binds to BDNF protein modified form CTD PMID:23135810 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of BDNF mRNA CTD PMID:24690739 copper(0) affects binding EXP 6480464 Copper binds to BDNF protein modified form CTD PMID:23135810 corticosterone decreases expression ISO RGD:10235 6480464 Corticosterone results in decreased expression of BDNF protein CTD PMID:22850435 corticosterone decreases expression ISO RGD:2202 6480464 Corticosterone results in decreased expression of BDNF mRNA CTD PMID:22244747 , PMID:27988398 corticosterone multiple interactions ISO RGD:2202 6480464 so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in decreased expression of BDNF mRNA] CTD PMID:27988398 corticosterone multiple interactions ISO RGD:10235 6480464 2-(3 more ... CTD PMID:22850435 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of BDNF mRNA CTD PMID:18687144 crocin-1 increases expression ISO RGD:2202 6480464 crocin results in increased expression of BDNF mRNA, crocin results in increased expression of BDNF protein CTD PMID:24401376 curcumin multiple interactions ISO RGD:2202 6480464 [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of BDNF mRNA], Curcumin inhibits the reaction [sodium arsenite results in decreased expression of BDNF protein] CTD PMID:17827730 more ... curcumin increases expression ISO RGD:2202 6480464 Curcumin results in increased expression of BDNF protein CTD PMID:17022948 curcumin affects expression ISO RGD:2202 6480464 Curcumin affects the expression of BDNF protein CTD PMID:17617388 curcumin multiple interactions ISO RGD:10235 6480464 [Docosahexaenoic Acids co-treated with Curcumin] results in increased expression of BDNF mRNA, Curcumin inhibits the reaction [Morphine results in increased expression of BDNF mRNA] CTD PMID:19033880 , PMID:22911773 cyclophosphamide increases expression ISO RGD:2202 6480464 Cyclophosphamide results in increased expression of BDNF mRNA CTD PMID:10683293 cyclosporin A increases methylation EXP 6480464 Cyclosporine results in increased methylation of BDNF promoter CTD PMID:27989131 cyfluthrin increases expression ISO RGD:2202 6480464 cyfluthrin results in increased expression of BDNF mRNA CTD PMID:16166269 cypermethrin multiple interactions ISO RGD:10235 6480464 cypermethrin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA] CTD PMID:11082455 cypermethrin increases expression ISO RGD:2202 6480464 cypermethrin results in increased expression of BDNF mRNA CTD PMID:16166269 dantrolene multiple interactions ISO RGD:10235 6480464 Dantrolene inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] CTD PMID:16553631 DDE multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 DDT multiple interactions ISO RGD:10235 6480464 [Permethrin co-treated with DDT co-treated with Diethylstilbestrol] inhibits the reaction [Potassium results in increased expression of BDNF mRNA], DDT inhibits the reaction [Potassium results in increased expression of BDNF mRNA] CTD PMID:15527870 decabromodiphenyl ether increases expression ISO RGD:2202 6480464 decabromobiphenyl ether results in increased expression of BDNF protein CTD PMID:18753049 decabromodiphenyl ether affects expression ISO RGD:10235 6480464 decabromobiphenyl ether affects the expression of BDNF protein CTD PMID:18061678 Deguelin multiple interactions ISO RGD:10235 6480464 deguelin inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] CTD PMID:17209049 dermatan sulfate affects binding EXP 6480464 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to BDNF protein CTD PMID:15385557 desipramine increases expression ISO RGD:10235 6480464 Desipramine results in increased expression of BDNF mRNA CTD PMID:15555640 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BDNF mRNA, Dexamethasone results in decreased expression of BDNF protein CTD PMID:15215491 , PMID:25047013 dexamethasone multiple interactions ISO RGD:2202 6480464 BDNF protein inhibits the reaction [Dexamethasone results in decreased expression of SLC17A7 mRNA] more ... CTD PMID:31518422 dexamethasone decreases expression ISO RGD:2202 6480464 Dexamethasone results in decreased expression of BDNF mRNA, Dexamethasone results in decreased expression of BDNF protein CTD PMID:29111458 , PMID:31518422 dexamethasone decreases acetylation ISO RGD:2202 6480464 Dexamethasone results in decreased acetylation of BDNF exon CTD PMID:31518422 diallyl disulfide decreases expression ISO RGD:10235 6480464 diallyl disulfide results in decreased expression of BDNF protein CTD PMID:23732363 diarsenic trioxide decreases expression ISO RGD:2202 6480464 Arsenic Trioxide results in decreased expression of BDNF mRNA CTD PMID:29223816 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BDNF protein CTD PMID:16711005 diarsenic trioxide multiple interactions ISO RGD:10235 6480464 Arsenic Trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein] CTD PMID:26114099 diazepam multiple interactions ISO RGD:2202 6480464 [Diazepam co-treated with Pentobarbital] promotes the reaction [Pilocarpine results in increased expression of BDNF mRNA] more ... CTD PMID:11259499 , PMID:9073163 diazepam increases expression ISO RGD:2202 6480464 Diazepam results in increased expression of BDNF protein CTD PMID:17442489 diazinon multiple interactions ISO RGD:10235 6480464 [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in decreased expression of BDNF mRNA CTD PMID:22428454 dibutyl phthalate increases expression ISO RGD:10235 6480464 Dibutyl Phthalate results in increased expression of BDNF mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 dibutyl phthalate increases expression ISO RGD:2202 6480464 Dibutyl Phthalate results in increased expression of BDNF mRNA, Dibutyl Phthalate results in increased expression of BDNF protein CTD PMID:21787579 dichloroacetic acid increases expression ISO RGD:10235 6480464 Dichloroacetic Acid results in increased expression of BDNF mRNA CTD PMID:28962523 diethylstilbestrol multiple interactions ISO RGD:10235 6480464 [Permethrin co-treated with DDT co-treated with Diethylstilbestrol] inhibits the reaction [Potassium results in increased expression of BDNF mRNA], Diethylstilbestrol inhibits the reaction [Potassium results in increased expression of BDNF mRNA] CTD PMID:15527870 diethylstilbestrol increases expression ISO RGD:2202 6480464 Diethylstilbestrol results in increased expression of BDNF mRNA CTD PMID:17292805 , PMID:27103539 dioxygen multiple interactions ISO RGD:10235 6480464 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] more ... CTD PMID:16553631 dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:26095976 dioxygen multiple interactions ISO RGD:2202 6480464 [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein more ... CTD PMID:18541227 , PMID:24718106 dioxygen decreases expression ISO RGD:2202 6480464 Oxygen deficiency results in decreased expression of BDNF mRNA CTD PMID:18541227 dioxygen decreases secretion ISO RGD:2202 6480464 Oxygen deficiency results in decreased secretion of BDNF protein CTD PMID:18541227 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of BDNF mRNA CTD PMID:24690739 dopamine increases abundance ISO RGD:10235 6480464 BDNF gene mutant form results in increased abundance of Dopamine CTD PMID:11421589 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDNF mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BDNF mRNA CTD PMID:29803840 echinacoside multiple interactions ISO RGD:2202 6480464 echinacoside inhibits the reaction [Rotenone results in decreased expression of BDNF protein], staurosporine aglycone inhibits the reaction [echinacoside inhibits the reaction [Rotenone results in decreased expression of BDNF protein]] CTD PMID:23189969 elemental selenium increases expression ISO RGD:2202 6480464 Selenium results in increased expression of BDNF protein CTD PMID:30695686 elemental selenium multiple interactions ISO RGD:2202 6480464 Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein] CTD PMID:30695686 endosulfan decreases expression ISO RGD:2202 6480464 Endosulfan results in decreased expression of BDNF mRNA CTD PMID:29391264 enzacamene multiple interactions ISO RGD:2202 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of BDNF mRNA CTD PMID:25607892 epoxiconazole multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 ethanol increases expression ISO RGD:2202 6480464 Ethanol results in increased expression of BDNF mRNA, Ethanol results in increased expression of BDNF protein CTD PMID:18713641 , PMID:23770283 ethanol multiple interactions ISO RGD:2202 6480464 [Dietary Fats co-treated with Ethanol] results in decreased expression of BDNF mRNA more ... CTD PMID:23770283 , PMID:30372842 ethanol decreases expression ISO RGD:2202 6480464 Ethanol results in decreased expression of BDNF mRNA, Ethanol results in decreased expression of BDNF protein CTD PMID:17685400 more ... ethanol increases expression ISO RGD:10235 6480464 Ethanol results in increased expression of BDNF CTD PMID:24584330 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of BDNF mRNA CTD PMID:23649840 etoposide increases expression EXP 6480464 Etoposide results in increased expression of BDNF mRNA CTD PMID:20573984 etoposide multiple interactions EXP 6480464 HIPK2 mutant form inhibits the reaction [Etoposide results in increased expression of BDNF mRNA] CTD PMID:20573984 eugenol increases expression ISO RGD:10235 6480464 Eugenol results in increased expression of BDNF mRNA CTD PMID:15157811 excitatory amino acid agonist decreases expression ISO RGD:2202 6480464 Excitatory Amino Acid Agonists results in decreased expression of BDNF mRNA CTD PMID:29425760 excitatory amino acid agonist multiple interactions ISO RGD:2202 6480464 agathisflavone inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BDNF mRNA], Estradiol inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BDNF mRNA] CTD PMID:29425760 fenvalerate increases expression ISO RGD:2202 6480464 fenvalerate results in increased expression of BDNF mRNA CTD PMID:16166269 fingolimod hydrochloride increases expression ISO RGD:10235 6480464 Fingolimod Hydrochloride results in increased expression of BDNF mRNA CTD PMID:24859201 fisetin multiple interactions ISO RGD:2202 6480464 fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein] CTD PMID:30890323 fluoranthene multiple interactions ISO RGD:10235 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of BDNF mRNA CTD PMID:28329830 fluoxetine increases response to substance ISO RGD:10235 6480464 BDNF protein results in increased susceptibility to Fluoxetine CTD PMID:22218094 fluoxetine multiple interactions ISO RGD:10235 6480464 Fluoxetine affects the reaction [sodium arsenate affects the expression of BDNF protein] CTD PMID:24952232 fluoxetine increases expression ISO RGD:10235 6480464 Fluoxetine results in increased expression of BDNF mRNA, Fluoxetine results in increased expression of BDNF protein CTD PMID:15555640 more ... fluoxetine decreases expression ISO RGD:2202 6480464 Fluoxetine results in decreased expression of BDNF mRNA CTD PMID:12504921 fluoxetine affects expression ISO RGD:2202 6480464 Fluoxetine affects the expression of BDNF mRNA CTD PMID:15381288 fluoxetine increases expression ISO RGD:2202 6480464 Fluoxetine results in increased expression of BDNF mRNA more ... CTD PMID:15381288 more ... fluoxetine affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Fluoxetine CTD PMID:20016225 fluoxetine increases response to substance EXP 6480464 BDNF protein results in increased susceptibility to Fluoxetine CTD PMID:20016225 fluoxetine multiple interactions ISO RGD:2202 6480464 [Fluoxetine co-treated with Amantadine] results in increased expression of BDNF mRNA, [Fluoxetine co-treated with Ketanserin] results in increased expression of BDNF mRNA CTD PMID:19211973 , PMID:21627639 fluoxetine decreases response to substance ISO RGD:10235 6480464 BDNF protein mutant form results in decreased susceptibility to Fluoxetine CTD PMID:22218094 folic acid multiple interactions ISO RGD:10235 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BDNF gene CTD PMID:20938992 formaldehyde increases expression ISO RGD:10235 6480464 Formaldehyde results in increased expression of BDNF mRNA CTD PMID:19904815 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of BDNF mRNA CTD PMID:23649840 Fusaric acid multiple interactions ISO RGD:2202 6480464 Glycyrrhizic Acid inhibits the reaction [Fusaric Acid results in decreased expression of BDNF protein] CTD PMID:31150628 Fusaric acid decreases expression ISO RGD:2202 6480464 Fusaric Acid results in decreased expression of BDNF protein CTD PMID:31150628 galactose multiple interactions ISO RGD:10235 6480464 lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA], lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein] CTD PMID:28974442 galactose decreases expression ISO RGD:10235 6480464 Galactose results in decreased expression of BDNF mRNA, Galactose results in decreased expression of BDNF protein CTD PMID:28974442 gallic acid multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF protein]] more ... CTD PMID:29061316 gallocatechin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF protein]] more ... CTD PMID:29061316 gamma-aminobutyric acid multiple interactions ISO RGD:2202 6480464 gamma-Aminobutyric Acid inhibits the reaction [decamethrin results in increased expression of BDNF exon] CTD PMID:22079160 gamma-hexachlorocyclohexane increases expression ISO RGD:2202 6480464 Hexachlorocyclohexane results in increased expression of BDNF protein CTD PMID:11279263 gemcitabine decreases expression EXP 6480464 gemcitabine results in decreased expression of BDNF protein CTD PMID:20531411 geraniol multiple interactions ISO RGD:10235 6480464 geraniol inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23943375 glycidol decreases expression ISO RGD:2202 6480464 glycidol results in decreased expression of BDNF mRNA CTD PMID:24915197 glycyrrhizinic acid multiple interactions ISO RGD:2202 6480464 Glycyrrhizic Acid inhibits the reaction [Fusaric Acid results in decreased expression of BDNF protein] CTD PMID:31150628 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of BDNF mRNA CTD PMID:29182611 haloperidol increases expression ISO RGD:10235 6480464 Haloperidol results in increased expression of BDNF protein CTD PMID:20554863 haloperidol multiple interactions ISO RGD:10235 6480464 Haloperidol inhibits the reaction [Cocaine results in decreased expression of BDNF protein] CTD PMID:20554863 haloperidol decreases expression ISO RGD:2202 6480464 Haloperidol results in decreased expression of BDNF mRNA, Haloperidol results in decreased expression of BDNF protein CTD PMID:11488957 more ... haloperidol multiple interactions ISO RGD:2202 6480464 BDNF protein inhibits the reaction [Haloperidol results in increased activity of CASP3 protein] more ... CTD PMID:15168214 more ... herbicide multiple interactions ISO RGD:2202 6480464 [[Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides, Industrial co-treated with Herbicides] affects the susceptibility to perfluorononanoic acid] which results in decreased expression of BDNF protein CTD PMID:25588985 heroin decreases expression ISO RGD:2202 6480464 Heroin results in decreased expression of BDNF mRNA CTD PMID:25643298 heroin decreases expression EXP 6480464 Heroin results in decreased expression of BDNF protein CTD PMID:17715210 heroin multiple interactions ISO RGD:2202 6480464 Heroin inhibits the reaction [CREB1 protein modified form binds to BDNF promoter] CTD PMID:25643298 hydrogen peroxide decreases expression ISO RGD:10235 6480464 Hydrogen Peroxide results in decreased expression of BDNF mRNA CTD PMID:22381256 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of BDNF protein CTD PMID:29061316 hydrogen peroxide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF protein]] more ... CTD PMID:29061316 hydrogen peroxide multiple interactions ISO RGD:10235 6480464 [shogaol co-treated with Hydrogen Peroxide] results in increased expression of BDNF mRNA more ... CTD PMID:22381256 imipramine increases expression ISO RGD:10235 6480464 Imipramine results in increased expression of BDNF mRNA CTD PMID:15157811 imipramine multiple interactions ISO RGD:2202 6480464 Rolipram promotes the reaction [Imipramine results in increased expression of BDNF mRNA] CTD PMID:8601816 imipramine increases expression ISO RGD:2202 6480464 Imipramine results in increased expression of BDNF mRNA CTD PMID:17950272 , PMID:8601816 imipramine affects expression ISO RGD:2202 6480464 Imipramine affects the expression of BDNF protein CTD PMID:17617388 kainic acid multiple interactions ISO RGD:2202 6480464 [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of BDNF mRNA], [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of BDNF mRNA] CTD PMID:17827730 kainic acid increases expression ISO RGD:2202 6480464 Kainic Acid results in increased expression of BDNF mRNA, Kainic Acid results in increased expression of BDNF protein CTD PMID:11279263 more ... ketamine multiple interactions ISO RGD:2202 6480464 Ketamine inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA] CTD PMID:8635431 ketanserin multiple interactions ISO RGD:2202 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of BDNF mRNA CTD PMID:21627639 KT 5823 multiple interactions ISO RGD:2202 6480464 KT 5823 inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid] CTD PMID:19428112 KT 5823 multiple interactions ISO RGD:10235 6480464 KT 5823 inhibits the reaction [2-(3 more ... CTD PMID:22850435 L-ascorbic acid increases expression ISO RGD:10235 6480464 Ascorbic Acid results in increased expression of BDNF mRNA CTD PMID:15305145 L-methionine multiple interactions ISO RGD:10235 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BDNF gene CTD PMID:20938992 lamotrigine increases expression ISO RGD:2202 6480464 lamotrigine results in increased expression of BDNF mRNA, lamotrigine results in increased expression of BDNF protein CTD PMID:18719996 lead diacetate multiple interactions ISO RGD:2202 6480464 [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of BDNF protein more ... CTD PMID:20375082 , PMID:23680456 lead diacetate affects expression ISO RGD:10235 6480464 lead acetate affects the expression of BDNF mRNA alternative form CTD PMID:24260418 lead diacetate decreases expression ISO RGD:10235 6480464 lead acetate results in decreased expression of BDNF mRNA alternative form CTD PMID:24260418 lead diacetate decreases expression ISO RGD:2202 6480464 lead acetate results in decreased expression of BDNF protein CTD PMID:20375082 more ... lead diacetate decreases secretion ISO RGD:2202 6480464 lead acetate results in decreased secretion of BDNF protein CTD PMID:20375082 lead diacetate decreases response to substance ISO RGD:2202 6480464 BDNF protein results in decreased susceptibility to lead acetate CTD PMID:20375082 lead(0) multiple interactions ISO RGD:2202 6480464 [Lead results in decreased expression of BDNF protein] which results in decreased phosphorylation of and results in decreased expression of MECP2 protein, BDNF protein inhibits the reaction [Lead results in decreased expression of GRIA2 protein] CTD PMID:22345308 , PMID:23719929 lead(0) decreases expression ISO RGD:2202 6480464 Lead results in decreased expression of BDNF mRNA, Lead results in decreased expression of BDNF protein CTD PMID:22345308 lead(2+) multiple interactions ISO RGD:2202 6480464 [Lead results in decreased expression of BDNF protein] which results in decreased phosphorylation of and results in decreased expression of MECP2 protein, BDNF protein inhibits the reaction [Lead results in decreased expression of GRIA2 protein] CTD PMID:22345308 , PMID:23719929 lead(2+) decreases expression ISO RGD:2202 6480464 Lead results in decreased expression of BDNF mRNA, Lead results in decreased expression of BDNF protein CTD PMID:22345308 linuron multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 lipopolysaccharide multiple interactions ISO RGD:2202 6480464 Simvastatin promotes the reaction [Lipopolysaccharides results in increased expression of BDNF mRNA] CTD PMID:18047562 lipopolysaccharide increases expression ISO RGD:2202 6480464 Lipopolysaccharides results in increased expression of BDNF mRNA CTD PMID:18047562 lithium atom affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Lithium CTD PMID:19018715 lithium atom decreases expression ISO RGD:2202 6480464 Lithium results in decreased expression of BDNF mRNA CTD PMID:21220416 lithium atom increases expression ISO RGD:2202 6480464 Lithium results in increased expression of BDNF mRNA, Lithium results in increased expression of BDNF protein CTD PMID:17442489 , PMID:9073163 lithium atom multiple interactions ISO RGD:2202 6480464 Diazepam inhibits the reaction [Lithium results in increased expression of BDNF mRNA] more ... CTD PMID:16460767 more ... lithium atom increases response to substance EXP 6480464 BDNF protein results in increased susceptibility to Lithium CTD PMID:19018715 lithium hydride affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Lithium CTD PMID:19018715 lithium hydride increases response to substance EXP 6480464 BDNF protein results in increased susceptibility to Lithium CTD PMID:19018715 lithium hydride increases expression ISO RGD:2202 6480464 Lithium results in increased expression of BDNF mRNA, Lithium results in increased expression of BDNF protein CTD PMID:17442489 , PMID:9073163 lithium hydride decreases expression ISO RGD:2202 6480464 Lithium results in decreased expression of BDNF mRNA CTD PMID:21220416 lithium hydride multiple interactions ISO RGD:2202 6480464 Diazepam inhibits the reaction [Lithium results in increased expression of BDNF mRNA] more ... CTD PMID:16460767 more ... lovastatin multiple interactions ISO RGD:2202 6480464 Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein] CTD PMID:24718106 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF protein]] more ... CTD PMID:17172126 more ... LY294002 multiple interactions ISO RGD:10235 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BDNF protein results in increased expression of PPP1R1B mRNA], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] CTD PMID:17209049 lycopene multiple interactions ISO RGD:10235 6480464 lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA], lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein] CTD PMID:28974442 maneb multiple interactions ISO RGD:10235 6480464 [Maneb co-treated with Paraquat] results in decreased expression of BDNF mRNA CTD PMID:23017109 maneb multiple interactions ISO RGD:2202 6480464 [Paraquat co-treated with Maneb] results in decreased expression of BDNF mRNA, [Paraquat co-treated with Maneb] results in decreased expression of BDNF protein CTD PMID:27460631 manganese atom multiple interactions ISO RGD:2202 6480464 [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of BDNF mRNA] more ... CTD PMID:17827730 , PMID:30951808 manganese atom decreases expression ISO RGD:2202 6480464 Manganese results in decreased expression of BDNF mRNA, Manganese results in decreased expression of BDNF protein CTD PMID:25099302 , PMID:29205667 manganese atom decreases expression ISO RGD:10235 6480464 Manganese results in decreased expression of BDNF protein CTD PMID:25099302 manganese(0) multiple interactions ISO RGD:2202 6480464 [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of BDNF mRNA] more ... CTD PMID:17827730 , PMID:30951808 manganese(0) decreases expression ISO RGD:2202 6480464 Manganese results in decreased expression of BDNF mRNA, Manganese results in decreased expression of BDNF protein CTD PMID:25099302 , PMID:29205667 manganese(0) decreases expression ISO RGD:10235 6480464 Manganese results in decreased expression of BDNF protein CTD PMID:25099302 manganese(II) chloride decreases expression ISO RGD:10235 6480464 manganese chloride results in decreased expression of BDNF mRNA CTD PMID:25698507 manganese(II) chloride increases methylation ISO RGD:2202 6480464 manganese chloride results in increased methylation of BDNF gene CTD PMID:28801915 manganese(II) chloride increases expression ISO RGD:2202 6480464 manganese chloride results in increased expression of BDNF mRNA CTD PMID:28801915 manganese(II) chloride multiple interactions ISO RGD:2202 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of BDNF protein more ... CTD PMID:30951808 melatonin multiple interactions ISO RGD:10235 6480464 Melatonin inhibits the reaction [Scopolamine results in decreased expression of BDNF protein] CTD PMID:29476728 melatonin multiple interactions ISO RGD:2202 6480464 Melatonin inhibits the reaction [[Dietary Fats co-treated with Ethanol] results in decreased expression of BDNF mRNA] more ... CTD PMID:30372842 mercury atom decreases expression EXP 6480464 Mercury results in decreased expression of BDNF mRNA CTD PMID:19937285 mercury atom affects response to substance EXP 6480464 BDNF polymorphism affects the susceptibility to Mercury CTD PMID:16301096 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDNF mRNA CTD PMID:27188386 mercury dichloride multiple interactions ISO RGD:10235 6480464 [Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of BDNF mRNA CTD PMID:21084432 mercury(0) decreases expression EXP 6480464 Mercury results in decreased expression of BDNF mRNA CTD PMID:19937285 mercury(0) affects response to substance EXP 6480464 BDNF polymorphism affects the susceptibility to Mercury CTD PMID:16301096 methamphetamine increases response to substance EXP 6480464 BDNF gene SNP results in increased susceptibility to Methamphetamine CTD PMID:20736000 methamphetamine increases expression ISO RGD:2202 6480464 Methamphetamine results in increased expression of BDNF protein CTD PMID:27373168 methamphetamine affects response to substance ISO RGD:10235 6480464 BDNF protein affects the susceptibility to Methamphetamine CTD PMID:15050682 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BDNF protein CTD PMID:16039058 methamphetamine affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Methamphetamine CTD PMID:19462300 methyl beta-cyclodextrin multiple interactions ISO RGD:10235 6480464 methyl-beta-cyclodextrin inhibits the reaction [BDNF protein results in decreased activity of HU 211] CTD PMID:20554863 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of BDNF mRNA CTD PMID:23649840 methylglyoxal increases expression EXP 6480464 Pyruvaldehyde results in increased expression of BDNF protein CTD PMID:25933243 methylglyoxal multiple interactions EXP 6480464 sulforafan promotes the reaction [Pyruvaldehyde results in increased expression of BDNF protein] CTD PMID:25933243 methyllycaconitine multiple interactions EXP 6480464 methyllycaconitine inhibits the reaction [Nicotine results in increased secretion of BDNF protein] CTD PMID:16790237 methylmercury chloride multiple interactions ISO RGD:10235 6480464 diphenyldiselenide inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein] CTD PMID:23954720 methylmercury chloride decreases expression ISO RGD:2202 6480464 methylmercuric chloride results in decreased expression of BDNF mRNA, methylmercuric chloride results in decreased expression of BDNF protein CTD PMID:29522201 , PMID:30890323 methylmercury chloride multiple interactions ISO RGD:2202 6480464 fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein] more ... CTD PMID:29522201 , PMID:30890323 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of BDNF mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:10235 6480464 methylmercuric chloride results in decreased expression of BDNF protein CTD PMID:23954720 methylphenidate affects expression ISO RGD:2202 6480464 Methylphenidate affects the expression of BDNF mRNA CTD PMID:19222557 methylphenidate multiple interactions EXP 6480464 [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [Methylphenidate inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]], Methylphenidate inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein] CTD PMID:24394491 methylphenidate decreases expression ISO RGD:10235 6480464 Methylphenidate results in decreased expression of BDNF mRNA CTD PMID:22470460 mevastatin multiple interactions ISO RGD:10235 6480464 mevastatin inhibits the reaction [BDNF protein results in decreased activity of HU 211] CTD PMID:20554863 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of BDNF protein CTD PMID:17464718 mifepristone multiple interactions ISO RGD:2202 6480464 Mifepristone inhibits the reaction [Dexamethasone results in decreased acetylation of BDNF exon], Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BDNF mRNA] CTD PMID:31518422 morphine decreases expression ISO RGD:10235 6480464 Morphine results in decreased expression of BDNF mRNA CTD PMID:25643298 morphine increases expression ISO RGD:10235 6480464 Morphine results in increased expression of BDNF mRNA CTD PMID:19033880 morphine multiple interactions ISO RGD:10235 6480464 BDNF protein inhibits the reaction [NR4A2 protein affects the susceptibility to Morphine], Curcumin inhibits the reaction [Morphine results in increased expression of BDNF mRNA] CTD PMID:19033880 , PMID:25643298 morphine multiple interactions ISO RGD:2202 6480464 Morphine inhibits the reaction [CREB1 protein modified form binds to BDNF promoter] more ... CTD PMID:25643298 morphine decreases expression ISO RGD:2202 6480464 Morphine results in decreased expression of BDNF mRNA, Morphine results in decreased expression of BDNF mRNA alternative form CTD PMID:25643298 muscimol multiple interactions ISO RGD:2202 6480464 Muscimol inhibits the reaction [decamethrin results in increased expression of BDNF exon] CTD PMID:22079160 N-acetyl-L-cysteine multiple interactions ISO RGD:10235 6480464 Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] CTD PMID:16553631 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of BDNF protein] CTD PMID:26138014 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:2202 6480464 Ethylnitrosourea results in increased mutagenesis of BDNF gene CTD PMID:16495775 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BDNF mRNA CTD PMID:25234470 N-methyl-4-phenylpyridinium decreases expression ISO RGD:2202 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BDNF mRNA CTD PMID:29631008 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:2202 6480464 Methylnitronitrosoguanidine results in increased expression of BDNF mRNA CTD PMID:15120970 N-methyl-N-nitrosourea increases expression ISO RGD:2202 6480464 Methylnitrosourea results in increased expression of BDNF mRNA CTD PMID:28688903 naproxen multiple interactions ISO RGD:2202 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of BDNF protein], Naproxen inhibits the reaction [Capsaicin affects the expression of BDNF protein] CTD PMID:22150557 Nicardipine multiple interactions ISO RGD:2202 6480464 Nicardipine inhibits the reaction [decamethrin results in increased expression of BDNF mRNA] CTD PMID:16166269 , PMID:22079160 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of BDNF mRNA CTD PMID:25583101 nicotine affects response to substance EXP 6480464 BDNF gene polymorphism affects the susceptibility to Nicotine CTD PMID:17186223 nicotine increases expression ISO RGD:2202 6480464 Nicotine results in increased expression of BDNF mRNA CTD PMID:9503263 , PMID:9832142 nicotine affects expression ISO RGD:2202 6480464 Nicotine affects the expression of BDNF mRNA CTD PMID:20426880 nicotine increases secretion EXP 6480464 Nicotine results in increased secretion of BDNF protein CTD PMID:16790237 nicotine multiple interactions EXP 6480464 methyllycaconitine inhibits the reaction [Nicotine results in increased secretion of BDNF protein] CTD PMID:16790237 nicotinic acid increases expression ISO RGD:2202 6480464 Niacin results in increased expression of BDNF protein CTD PMID:20671245 nifedipine multiple interactions ISO RGD:2202 6480464 Nifedipine inhibits the reaction [3-Pyridinecarboxylic acid, 1 more ... CTD PMID:11279263 nitric oxide increases chemical synthesis EXP 6480464 BDNF protein results in increased chemical synthesis of Nitric Oxide CTD PMID:17172126 nitric oxide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BDNF protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:17172126 ochratoxin A increases expression ISO RGD:2202 6480464 ochratoxin A results in increased expression of BDNF mRNA CTD PMID:27346841 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of BDNF mRNA, olanzapine results in increased expression of BDNF protein CTD PMID:29182611 olanzapine increases expression ISO RGD:2202 6480464 olanzapine results in increased expression of BDNF mRNA, olanzapine results in increased expression of BDNF protein CTD PMID:12478621 , PMID:17442489 ouabain multiple interactions ISO RGD:2202 6480464 Lithium inhibits the reaction [Ouabain results in decreased expression of BDNF protein] CTD PMID:19954800 ouabain decreases expression ISO RGD:2202 6480464 Ouabain results in decreased expression of BDNF protein CTD PMID:19954800 Oxadiazon multiple interactions EXP 6480464 ACYP2 protein affects the reaction [oxadiazon inhibits the reaction [BDNF protein results in increased expression of GAP43 protein]], oxadiazon inhibits the reaction [BDNF protein results in increased expression of GAP43 protein] CTD PMID:30391265 oxidopamine decreases expression ISO RGD:10235 6480464 Oxidopamine results in decreased expression of BDNF protein CTD PMID:29054324 oxidopamine multiple interactions ISO RGD:10235 6480464 chrysin inhibits the reaction [Oxidopamine results in decreased expression of BDNF protein] CTD PMID:29054324 ozone increases expression ISO RGD:10235 6480464 Ozone results in increased expression of BDNF mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:10235 6480464 [Ozone co-treated with Vehicle Emissions] results in increased expression of BDNF mRNA CTD PMID:23358141 ozone increases expression ISO RGD:2202 6480464 Ozone results in increased expression of BDNF mRNA CTD PMID:16716893 paliperidone palmitate increases expression ISO RGD:2202 6480464 Paliperidone Palmitate results in increased expression of BDNF mRNA CTD PMID:21220416 panaxydol multiple interactions ISO RGD:2202 6480464 panaxydol inhibits the reaction [Oxygen deficiency results in decreased expression of BDNF mRNA] more ... CTD PMID:18541227 , PMID:18805406 papaverine increases expression ISO RGD:2202 6480464 Papaverine results in increased expression of BDNF mRNA CTD PMID:8601816 paracetamol affects expression ISO RGD:10235 6480464 Acetaminophen affects the expression of BDNF mRNA, Acetaminophen affects the expression of BDNF protein CTD PMID:17562736 , PMID:24361869 paraldehyde multiple interactions ISO RGD:2202 6480464 Paraldehyde promotes the reaction [Pilocarpine results in increased expression of BDNF mRNA] CTD PMID:11259499 paraquat multiple interactions ISO RGD:10235 6480464 [Maneb co-treated with Paraquat] results in decreased expression of BDNF mRNA CTD PMID:23017109 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BDNF mRNA CTD PMID:29454966 paraquat multiple interactions ISO RGD:2202 6480464 [Paraquat co-treated with Maneb] results in decreased expression of BDNF mRNA, [Paraquat co-treated with Maneb] results in decreased expression of BDNF protein CTD PMID:27460631 parathion-methyl increases expression ISO RGD:2202 6480464 Methyl Parathion results in increased expression of BDNF mRNA, Methyl Parathion results in increased expression of BDNF protein CTD PMID:17893397 paroxetine increases expression ISO RGD:10235 6480464 Paroxetine results in increased expression of BDNF mRNA, Paroxetine results in increased expression of BDNF protein CTD PMID:21301813 pentetrazol increases expression ISO RGD:2202 6480464 Pentylenetetrazole results in increased expression of BDNF mRNA, Pentylenetetrazole results in increased expression of BDNF protein CTD PMID:11279263 pentobarbital multiple interactions ISO RGD:2202 6480464 [Diazepam co-treated with Pentobarbital] promotes the reaction [Pilocarpine results in increased expression of BDNF mRNA] more ... CTD PMID:11259499 , PMID:8405262 pentobarbital decreases expression ISO RGD:2202 6480464 Pentobarbital results in decreased expression of BDNF mRNA CTD PMID:8247360 perfluorononanoic acid multiple interactions ISO RGD:2202 6480464 [[Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides, Industrial co-treated with Herbicides] affects the susceptibility to perfluorononanoic acid] which results in decreased expression of BDNF protein CTD PMID:25588985 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:2202 6480464 2 more ... CTD PMID:21436126 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:2202 6480464 perfluorooctane sulfonic acid results in decreased expression of BDNF protein CTD PMID:25524167 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2202 6480464 perfluorooctane sulfonic acid results in increased expression of BDNF mRNA, perfluorooctane sulfonic acid results in increased expression of BDNF protein CTD PMID:21436126 , PMID:25524167 permethrin multiple interactions ISO RGD:10235 6480464 [Permethrin co-treated with DDT co-treated with Diethylstilbestrol] inhibits the reaction [Potassium results in increased expression of BDNF mRNA] more ... CTD PMID:11082455 , PMID:15527870 permethrin increases expression ISO RGD:2202 6480464 Permethrin results in increased expression of BDNF mRNA CTD PMID:19017407 permethrin decreases expression ISO RGD:10235 6480464 Permethrin results in decreased expression of BDNF mRNA CTD PMID:12111003 peroxynitrous acid multiple interactions ISO RGD:2202 6480464 BDNF protein promotes the reaction [Peroxynitrous Acid results in increased phosphorylation of AKT1 protein], Peroxynitrous Acid promotes the reaction [BDNF protein results in increased phosphorylation of AKT1 protein] CTD PMID:17302912 phenobarbital affects expression ISO RGD:10235 6480464 Phenobarbital affects the expression of BDNF mRNA CTD PMID:23091169 phenylephrine increases expression ISO RGD:2202 6480464 Phenylephrine results in increased expression of BDNF mRNA CTD PMID:18158353 picrotoxin decreases methylation ISO RGD:10235 6480464 Picrotoxin results in decreased methylation of BDNF promoter CTD PMID:18184782 picrotoxin increases expression ISO RGD:2202 6480464 Picrotoxin results in increased expression of BDNF protein CTD PMID:11279263 picrotoxin increases expression ISO RGD:10235 6480464 Picrotoxin results in increased expression of BDNF mRNA CTD PMID:18184782 poly(I:C) multiple interactions ISO RGD:10235 6480464 [Poly I-C results in increased susceptibility to 4-iodo-2 more ... CTD PMID:24889602 potassium atom multiple interactions ISO RGD:10235 6480464 [Permethrin co-treated with DDT co-treated with Diethylstilbestrol] inhibits the reaction [Potassium results in increased expression of BDNF mRNA] more ... CTD PMID:15527870 potassium atom increases expression ISO RGD:2202 6480464 [Potassium results in increased expression of BDNF] which results in increased expression of NTF3, Potassium results in increased expression of BDNF CTD PMID:8978711 potassium chloride multiple interactions ISO RGD:10235 6480464 BDNF promoter modified form affects the reaction [Potassium Chloride results in increased expression of BDNF mRNA] more ... CTD PMID:14593183 potassium chloride increases expression ISO RGD:10235 6480464 Potassium Chloride results in increased expression of BDNF mRNA CTD PMID:14593183 potassium chloride decreases methylation ISO RGD:10235 6480464 Potassium Chloride results in decreased methylation of BDNF promoter CTD PMID:14593183 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of BDNF mRNA CTD PMID:22714537 prochloraz multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 procymidone multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of BDNF mRNA CTD PMID:18070364 progesterone increases expression ISO RGD:10235 6480464 Progesterone results in increased expression of BDNF mRNA, Progesterone results in increased expression of BDNF protein CTD PMID:17549730 , PMID:23157231 progesterone multiple interactions ISO RGD:2202 6480464 Progesterone inhibits the reaction [Estradiol results in increased expression of BDNF protein] CTD PMID:15570173 progesterone multiple interactions ISO RGD:10235 6480464 Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased expression of BDNF mRNA] CTD PMID:17052708 progesterone affects localization ISO RGD:10235 6480464 Progesterone affects the localization of BDNF protein CTD PMID:17052708 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of BDNF mRNA CTD PMID:26079696 pyrethrins multiple interactions ISO RGD:10235 6480464 Pyrethrins inhibits the reaction [Potassium results in increased expression of BDNF mRNA] CTD PMID:15527870 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [BDNF protein results in increased expression of SOD2 protein] CTD PMID:22261313 quercetin increases expression ISO RGD:10235 6480464 Quercetin results in increased expression of BDNF mRNA CTD PMID:30368985 quetiapine fumarate increases expression ISO RGD:2202 6480464 Quetiapine Fumarate results in increased expression of BDNF protein CTD PMID:17442489 quinolinic acid increases expression ISO RGD:2202 6480464 Quinolinic Acid results in increased expression of BDNF mRNA CTD PMID:15698628 reserpine decreases expression ISO RGD:10235 6480464 Reserpine results in decreased expression of BDNF protein CTD PMID:26114099 reserpine multiple interactions ISO RGD:10235 6480464 arsenic trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein] CTD PMID:26114099 resveratrol affects expression ISO RGD:2202 6480464 resveratrol affects the expression of BDNF CTD PMID:23850968 resveratrol increases expression ISO RGD:10235 6480464 resveratrol results in increased expression of BDNF mRNA, resveratrol results in increased expression of BDNF protein CTD PMID:24125781 resveratrol multiple interactions ISO RGD:2202 6480464 [Ethanol co-treated with resveratrol] results in increased expression of BDNF mRNA, resveratrol promotes the reaction [Ethanol results in increased expression of BDNF protein] CTD PMID:23770283 resveratrol decreases expression ISO RGD:10235 6480464 resveratrol results in decreased expression of BDNF protein CTD PMID:23105098 risperidone decreases expression ISO RGD:2202 6480464 Risperidone results in decreased expression of BDNF mRNA CTD PMID:12393228 risperidone multiple interactions EXP 6480464 BDNF gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein] CTD PMID:19997080 risperidone multiple interactions ISO RGD:2202 6480464 Risperidone inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA] CTD PMID:17442543 ritanserin increases expression ISO RGD:2202 6480464 Ritanserin results in increased expression of BDNF mRNA CTD PMID:12393228 rolipram multiple interactions ISO RGD:2202 6480464 Rolipram promotes the reaction [Imipramine results in increased expression of BDNF mRNA] CTD PMID:8601816 rolipram increases expression ISO RGD:2202 6480464 Rolipram results in increased expression of BDNF mRNA CTD PMID:8601816 romidepsin multiple interactions ISO RGD:2202 6480464 romidepsin inhibits the reaction [Dexamethasone results in decreased acetylation of BDNF exon], romidepsin inhibits the reaction [Dexamethasone results in decreased expression of BDNF mRNA] CTD PMID:31518422 rotenone multiple interactions ISO RGD:10235 6480464 BDNF protein affects the reaction [PITX3 protein results in decreased susceptibility to Rotenone] CTD PMID:18646205 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BDNF mRNA CTD PMID:29955902 rotenone decreases expression ISO RGD:2202 6480464 Rotenone results in decreased expression of BDNF mRNA, Rotenone results in decreased expression of BDNF protein CTD PMID:17442543 more ... rotenone multiple interactions ISO RGD:2202 6480464 Apigenin inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA] more ... CTD PMID:17442543 more ... salvianolic acid B increases expression ISO RGD:10235 6480464 salvianolic acid B results in increased expression of BDNF protein CTD PMID:24991814 salvianolic acid B multiple interactions ISO RGD:10235 6480464 salvianolic acid B inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:24991814 saxagliptin multiple interactions ISO RGD:2202 6480464 saxagliptin inhibits the reaction [Rotenone results in decreased expression of BDNF protein] CTD PMID:25446674 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDNF mRNA CTD PMID:27188386 scopolamine multiple interactions ISO RGD:2202 6480464 Scopolamine inhibits the reaction [Dizocilpine Maleate affects the expression of BDNF mRNA], Scopolamine inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA] CTD PMID:8405262 , PMID:8635431 scopolamine multiple interactions ISO RGD:10235 6480464 Ashwagandha inhibits the reaction [Scopolamine results in decreased expression of BDNF mRNA] more ... CTD PMID:22096544 more ... scopolamine decreases expression ISO RGD:10235 6480464 Scopolamine results in decreased expression of BDNF mRNA, Scopolamine results in decreased expression of BDNF protein CTD PMID:22096544 more ... selenium atom multiple interactions ISO RGD:2202 6480464 Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein] CTD PMID:30695686 selenium atom increases expression ISO RGD:2202 6480464 Selenium results in increased expression of BDNF protein CTD PMID:30695686 serotonin multiple interactions ISO RGD:2202 6480464 [Butyrates co-treated with Serotonin] results in increased expression of BDNF mRNA more ... CTD PMID:19360904 serotonin multiple interactions ISO RGD:10235 6480464 Serotonin analog inhibits the reaction [Scopolamine results in decreased expression of BDNF protein] CTD PMID:26408985 sertraline increases expression ISO RGD:10235 6480464 Sertraline results in increased expression of BDNF protein CTD PMID:18403212 silver atom increases expression EXP 6480464 Silver results in increased expression of BDNF mRNA CTD PMID:26551752 silver(0) increases expression EXP 6480464 Silver results in increased expression of BDNF mRNA CTD PMID:26551752 simvastatin increases expression ISO RGD:2202 6480464 Simvastatin results in increased expression of BDNF CTD PMID:20851742 simvastatin multiple interactions ISO RGD:2202 6480464 Simvastatin promotes the reaction [Lipopolysaccharides results in increased expression of BDNF mRNA] CTD PMID:18047562 sirolimus multiple interactions ISO RGD:10235 6480464 Sirolimus inhibits the reaction [BDNF protein results in increased expression of PPP1R1B mRNA], Sirolimus inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] CTD PMID:17209049 SKF-96365 hydrochloride multiple interactions ISO RGD:10235 6480464 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] CTD PMID:16553631 SL-327 multiple interactions ISO RGD:10235 6480464 SL 327 inhibits the reaction [Dronabinol results in increased expression of BDNF mRNA] CTD PMID:12657697 SL-327 increases response to substance ISO RGD:10235 6480464 BDNF gene mutant form results in increased susceptibility to SL 327 CTD PMID:16945347 sodium arsenate multiple interactions ISO RGD:10235 6480464 Fluoxetine affects the reaction [sodium arsenate affects the expression of BDNF protein] CTD PMID:24952232 sodium arsenate affects expression ISO RGD:10235 6480464 sodium arsenate affects the expression of BDNF protein CTD PMID:24952232 sodium arsenite multiple interactions ISO RGD:2202 6480464 [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of BDNF protein, Curcumin inhibits the reaction [sodium arsenite results in decreased expression of BDNF protein] CTD PMID:23680456 more ... sodium arsenite decreases expression ISO RGD:2202 6480464 sodium arsenite results in decreased expression of BDNF protein CTD PMID:27966075 , PMID:29723552 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BDNF mRNA CTD PMID:12760830 sodium fluoride multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Fluoride results in increased expression of BDNF protein] CTD PMID:30130557 sodium fluoride increases expression ISO RGD:2202 6480464 Sodium Fluoride results in increased expression of BDNF protein CTD PMID:30130557 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of BDNF protein CTD PMID:30130557 Soman increases expression ISO RGD:2202 6480464 Soman results in increased expression of BDNF mRNA CTD PMID:19281266 , PMID:26205086 sulforaphane increases expression EXP 6480464 sulforafan results in increased expression of BDNF protein CTD PMID:25933243 sulforaphane multiple interactions EXP 6480464 sulforafan promotes the reaction [Pyruvaldehyde results in increased expression of BDNF protein] CTD PMID:25933243 sumatriptan multiple interactions ISO RGD:2202 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of BDNF protein], Sumatriptan inhibits the reaction [Capsaicin affects the expression of BDNF protein] CTD PMID:22150557 tacrine multiple interactions ISO RGD:10235 6480464 Tacrine inhibits the reaction [Scopolamine results in decreased expression of BDNF protein] CTD PMID:26408985 tacrolimus hydrate multiple interactions ISO RGD:2202 6480464 Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon] more ... CTD PMID:22079160 tamibarotene multiple interactions EXP 6480464 [tamibarotene co-treated with BDNF] results in increased expression of NTRK2 CTD PMID:19182380 tamibarotene multiple interactions ISO RGD:2202 6480464 BDNF affects the reaction [tamibarotene results in increased phosphorylation of MAPK1 protein] more ... CTD PMID:19457078 tamibarotene increases expression ISO RGD:2202 6480464 tamibarotene results in increased expression of BDNF mRNA CTD PMID:19457078 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of BDNF mRNA CTD PMID:14699072 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [arsenite results in decreased expression of BDNF mRNA] CTD PMID:23744399 telmisartan multiple interactions ISO RGD:10235 6480464 telmisartan inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of BDNF mRNA CTD PMID:15336504 Testosterone propionate increases expression ISO RGD:2202 6480464 Testosterone Propionate results in increased expression of BDNF mRNA CTD PMID:19427307 tetrodotoxin multiple interactions ISO RGD:10235 6480464 Tetrodotoxin inhibits the reaction [Azacitidine results in decreased methylation of BDNF promoter], Tetrodotoxin inhibits the reaction [Azacitidine results in increased expression of BDNF mRNA] CTD PMID:18184782 tetrodotoxin multiple interactions EXP 6480464 3 more ... CTD PMID:26095976 tetrodotoxin multiple interactions ISO RGD:2202 6480464 Tetrodotoxin inhibits the reaction [decamethrin results in increased expression of BDNF mRNA], Tetrodotoxin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA] CTD PMID:16166269 titanium dioxide decreases expression ISO RGD:10235 6480464 titanium dioxide results in decreased expression of BDNF mRNA CTD PMID:29264374 toluene decreases expression ISO RGD:10235 6480464 Toluene results in decreased expression of BDNF mRNA CTD PMID:17481687 toluene increases expression ISO RGD:10235 6480464 Toluene results in increased expression of BDNF mRNA CTD PMID:17870172 more ... topiramate multiple interactions ISO RGD:2202 6480464 topiramate inhibits the reaction [3-nitropropionic acid results in decreased expression of BDNF protein] CTD PMID:29753867 torcetrapib increases expression EXP 6480464 torcetrapib results in increased expression of BDNF mRNA CTD PMID:23228038 tranylcypromine increases expression ISO RGD:2202 6480464 Tranylcypromine results in increased expression of BDNF mRNA CTD PMID:8601816 triacsin C decreases expression EXP 6480464 triacsin C results in decreased expression of BDNF mRNA CTD PMID:16704987 triazolam multiple interactions ISO RGD:10235 6480464 [Triazolam co-treated with zolpidem] results in decreased expression of BDNF protein CTD PMID:24367698 triazophos decreases expression ISO RGD:2202 6480464 triazophos results in decreased expression of BDNF mRNA, triazophos results in decreased expression of BDNF protein CTD PMID:23949197 trichloroethene multiple interactions ISO RGD:10235 6480464 [Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of BDNF mRNA CTD PMID:21084432 trichloroethene decreases expression ISO RGD:10235 6480464 Trichloroethylene results in decreased expression of BDNF mRNA CTD PMID:22421312 trichostatin A increases expression ISO RGD:2202 6480464 trichostatin A results in increased expression of BDNF mRNA CTD PMID:19476549 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of BDNF mRNA CTD PMID:24935251 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of BDNF mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:10235 6480464 trichostatin A inhibits the reaction [BDNF protein results in increased expression of NAB2 protein], trichostatin A inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] CTD PMID:24204683 trichostatin A multiple interactions ISO RGD:2202 6480464 [trichostatin A co-treated with Serotonin] results in increased expression of BDNF mRNA CTD PMID:19360904 undecane decreases expression ISO RGD:2202 6480464 undecane results in decreased expression of BDNF protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:10235 6480464 Valproic Acid results in decreased expression of BDNF mRNA CTD PMID:20603192 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of BDNF mRNA CTD PMID:23179753 more ... valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of BDNF mRNA CTD PMID:25979313 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of BDNF gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:2202 6480464 Valproic Acid results in decreased expression of BDNF mRNA CTD PMID:23665938 more ... valproic acid multiple interactions ISO RGD:10235 6480464 [Valproic Acid co-treated with BDNF protein] results in decreased expression of BCL11B protein more ... CTD PMID:24204683 valproic acid increases expression ISO RGD:2202 6480464 Valproic Acid results in increased expression of BDNF protein CTD PMID:17442489 valproic acid multiple interactions ISO RGD:2202 6480464 [Valproic Acid co-treated with Serotonin] results in increased expression of BDNF mRNA, Valproic Acid inhibits the reaction [Dextroamphetamine results in decreased expression of BDNF protein] CTD PMID:16460767 , PMID:19360904 valproic acid increases expression ISO RGD:10235 6480464 Valproic Acid results in increased expression of BDNF mRNA CTD PMID:10689198 venlafaxine hydrochloride increases expression ISO RGD:2202 6480464 Venlafaxine Hydrochloride results in increased expression of BDNF mRNA CTD PMID:17950272 veratridine multiple interactions ISO RGD:10235 6480464 cypermethrin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA], Permethrin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA] CTD PMID:11082455 veratridine increases expression ISO RGD:2202 6480464 Veratridine results in increased expression of BDNF mRNA CTD PMID:16166269 veratridine multiple interactions ISO RGD:2202 6480464 Tetrodotoxin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA] CTD PMID:16166269 veratridine increases expression ISO RGD:10235 6480464 Veratridine results in increased expression of BDNF mRNA CTD PMID:11082455 vinclozolin multiple interactions ISO RGD:2202 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 vinclozolin affects expression ISO RGD:2202 6480464 vinclozolin affects the expression of BDNF mRNA CTD PMID:19015723 VX nerve agent increases expression ISO RGD:10235 6480464 VX results in increased expression of BDNF mRNA, VX results in increased expression of BDNF protein CTD PMID:22240983 wortmannin multiple interactions ISO RGD:10235 6480464 wortmannin inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] CTD PMID:17209049 xenon atom increases expression ISO RGD:2202 6480464 Xenon results in increased expression of BDNF protein CTD PMID:16034370 xenon(0) increases expression ISO RGD:2202 6480464 Xenon results in increased expression of BDNF protein CTD PMID:16034370 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of BDNF mRNA CTD PMID:24412706 zinc atom multiple interactions ISO RGD:10235 6480464 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Zinc results in increased expression of BDNF mRNA] more ... CTD PMID:21615740 zinc atom increases expression ISO RGD:10235 6480464 Zinc deficiency results in increased expression of BDNF protein, Zinc results in increased expression of BDNF mRNA CTD PMID:20101602 , PMID:21615740 zinc dichloride multiple interactions ISO RGD:2202 6480464 zinc chloride affects the reaction [Cadmium Chloride affects the expression of BDNF mRNA] CTD PMID:29548726 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of BDNF mRNA CTD PMID:16330358 zinc(0) multiple interactions ISO RGD:10235 6480464 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Zinc results in increased expression of BDNF mRNA] more ... CTD PMID:21615740 zinc(0) increases expression ISO RGD:10235 6480464 Zinc deficiency results in increased expression of BDNF protein, Zinc results in increased expression of BDNF mRNA CTD PMID:20101602 , PMID:21615740 zolpidem multiple interactions ISO RGD:10235 6480464 [Triazolam co-treated with zolpidem] results in decreased expression of BDNF protein more ... CTD PMID:24367698 zolpidem decreases expression ISO RGD:10235 6480464 zolpidem results in decreased expression of BDNF mRNA CTD PMID:24367698
Gene-Chemical Interaction Annotations